This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Charles C. Sprague, M.D.

Arch Intern Med. 1961;107(1):4-5.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Perhaps no other single mode of therapy is applied with such empiricism and as illogically as the administration of hemostatic agents. This criticism does not apply to the administration of specific therapy where the diagnosis has been established, such as the use of antihemophilic globulin in a patient with hemophilia. Rather, it is directed to the inappropriate use of an ever-increasing number of hemostatic agents some of which would seem to have little chance of providing significant benefit to the patient.

It is understandable that the physician faced with the problem of severe hemorrhage of unexplained etiology is going to resort to any therapeutic measure that may be beneficial no matter how empirical the approach. Unfortunately, and at times inexcusably, this approach to therapy often precedes an adequate appraisal of the hemostatic mechanism in the bleeding patient. In many respects this train of events is "a sign of the times" . . . [Full Text PDF of this Article]

Author Affiliations
Tulane University School of Medicine 1430 Tulane Ave. New Orleans 12, La.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?